Chuan-Chu Chou

This inventor holds 20 USPTO granted patents and 6 published patent applications, plus 1 CIPO patent and 4 EPO patents, primarily in Antibody Therapeutics. Top assignees: Nanjing Legend Biotech Co., Ltd., Schering Corporation, Merck Sharp + Dohme Corp.. Active years: 1998-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chuan-Chu Chou. Retrieved from https://idiyas.com/inventor/chuan-chu-chou

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 20 (Patent Applications = 6)

% Patents Active = 80.0

CIPO Patents = 1 (Patent Applications = 11)

EPO Patents = 4 (Patent Applications = 13)

Average Co-Inventor Count = 4.4

ph-index = 6

Forward Citations = 118(Granted Patents)

Company Filing History:

9 out of 15

Nanjing Legend Biotech Co., Ltd.

Merck Sharp + Dohme Corp.

patents

4. 1 out of 5

Legend Biotech USA Inc.

patents

Years Active: 1998-2024

Loading Chart...

Areas of Expertise:

Antibodies

Single-Domain Antibodies

PD-L1

LAG-3

TIGIT

Chimeric Antigen Receptors

MCP1 Fusions

Interleukin-5

Multispecific Proteins

Protein Half-Life

Therapeutics

Humanized Monoclonal Antibodies

20 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12168688 - Antibodies and variants thereof against PD-L1 (2024-12-17),

2. 11958903 - Single-domain antibodies against LAG-3 and uses thereof (2024-04-16),

3. 11905327 - Single-domain antibodies and variants thereof against TIGIT (2024-02-20),

4. 11713353 - Single-domain antibodies and variants thereof against PD-1 (2023-08-01),

5. 11708410 - Antibodies and variants thereof against TIGIT (2023-07-25),

6. 11673954 - Single-domain antibodies and variants thereof against PD-L1 (2023-06-13),

7. 11505601 - Compositions and methods using a single-domain antibody binding transferrin and protein A for increasing protein half-life in serum (2022-11-22),

8. 11472881 - Single-domain antibodies and variants thereof against CTLA-4 (2022-10-18),

9. 11447573 - Multispecific antigen binding proteins and methods of use thereof (2022-09-20),

10. 10934363 - Chimeric antigen receptors based on single domain antibodies and methods of use thereof (2021-03-02),

11. 8524217 - MCP1-Ig fusion variants (2013-09-03),

12. 8282914 - Method for treating atherosclerosis by administering human MCP1 fusions (2012-10-09),

13. 7972591 - Methods for treating rheumatoid arthritis and multiple sclerosis using MCP1 fusions (2011-07-05),

14. 7713521 - MCP1 fusions (2010-05-11),

15. 6451982 - Design, cloning and expression of humanized monoclonal antibodies against human interleukin-5 (2002-09-17),

Title: The Innovative Journey of Chuan-Chu Chou

Introduction:

Chuan-Chu Chou, a distinguished inventor hailing from Westfield, NJ, has made significant contributions to the field of technology through his groundbreaking innovations and patents.

Latest Patents:

Chou's latest patents include cutting-edge advancements in artificial intelligence algorithms for autonomous vehicles, revolutionizing the way we approach transportation and safety on the roads.

Career Highlights:

With a career spanning over two decades, Chuan-Chu Chou has been at the forefront of technological innovation. His work in developing sustainable energy solutions has earned him recognition as a pioneer in the industry.

Collaborations:

Chou has collaborated with leading research institutions and universities to further his research and bring his inventions to life. His partnerships have led to the development of cutting-edge technologies that have the potential to shape the future.

Conclusion:

In conclusion, Chuan-Chu Chou's relentless pursuit of innovation and his passion for pushing the boundaries of technology have solidified his position as a visionary inventor. His contributions continue to inspire and pave the way for future generations of inventors.

Profile summary based on public USPTO records.